Rheumatoid Arthritis - 2/8

Entry	Author	Date	Location
Alder Rival Wins FDA Approval	Luke Timmerman	01/09/10	Seattle
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO	Luke Timmerman	01/07/10	Boston
Alder Rises From Ashes of Layoffs to Become Seattle Biotech Force	Luke Timmerman	01/04/10	Seattle
Alkermes Bets $10M on Long-Lasting Drug Technology from Startup Neighbor, Acceleron	Luke Timmerman	12/03/09	Boston
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News	Luke Timmerman	11/12/09	Seattle
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money	Luke Timmerman	11/11/09	Seattle
Clearwire Closes $1.5B, Alder Scores $1B Partnership, Software Financings Are Down, & More Seattle-Area Deals News	Gregory T. Huang	11/10/09	Seattle
Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion	Luke Timmerman	11/10/09	Seattle
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney	Luke Timmerman	10/14/09	Seattle
“Don’t Touch My Bags If You Please, Mr. Customs Man”	Stewart Lyman	10/05/09	Seattle
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News	Luke Timmerman	09/17/09	Seattle
Zymo Drug Fails Arthritis Trials	Luke Timmerman	09/10/09	Seattle
Trubion Gets $20M Upfront in Leukemia Drug Partnership With Facet; Shares Boom	Luke Timmerman	08/28/09	Seattle
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner	Ryan McBride	08/07/09	Boston
Alder Expands Partnership with Schering-Plough, Adds “Significant” Upfront Cash	Luke Timmerman	06/08/09	Seattle
Alder Drug Fights Cancer Fatigue	Luke Timmerman	06/01/09	Seattle
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown	Luke Timmerman	05/07/09	Seattle
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation	Luke Timmerman	05/05/09	Seattle
Biotech Neighbors, VLST and Novo Nordisk, Forge Alliance in Seattle’s South Lake Union	Luke Timmerman	04/06/09	Seattle
Trubion Starts Lupus Trial	Luke Timmerman	03/25/09	Seattle
Trubion Cuts One-Fourth of Workforce	Luke Timmerman	02/25/09	Seattle
Seattle Genetics Raises Dough, Trubion Feels Fallout of Pfizer Deal, Novo Sets Up Shop, & More Seattle-Area Life Sciences News	Luke Timmerman	01/29/09	Seattle
Pfizer’s Bid For Wyeth Sends Ripples Through Trubion Pharmaceuticals, Seattle Biotechs	Luke Timmerman	01/27/09	Seattle
Pfizer-Wyeth Combo’s Impact on San Diego Biotech: Bad for Dealmaking, Good for Shareholders	Luke Timmerman	01/27/09	San Diego
Axikin Raises $3M After Spinning Out From Actimis	Ryan McBride	01/22/09	San Diego
Burnham Cuts Deal With Johnson & Johnson In First Sweeping Big Pharma Partnership	Luke Timmerman	01/13/09	San Diego
CalciMedica Finds a New Pathway to Fight Autoimmune Disorders	Bruce V. Bigelow	01/09/09	San Diego
Zymo Boss Sees Immunex Parallel, Arch Startup Bags $7M, Northstar Folds, & More Seattle-Area Life Sciences News	Luke Timmerman	01/08/09	Seattle
Washington’s Life Sciences Ambassador, Jack Faris, Exits the Stage	Luke Timmerman	12/29/08	Seattle
Archemix Secures Partnership with Glaxo to Develop Drugs for Inflammatory Diseases	Luke Timmerman	12/23/08	Boston
Page 2 of 3	« previous page · next page »

Entry

Author

Date

Location

Alder Rival Wins FDA Approval

Luke Timmerman

01/09/10

Seattle

Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO

Luke Timmerman

01/07/10

Boston